Cell and Gene Therapy Bioassay Service Market, 2021 – 2030
To order this 305+
page report, which features 215+ figures and 250+ tables, please visit this link
Key Inclusions
§
A detailed assessment
of the overall market landscape of the cell and gene therapy bioassay services market,
providing information on their year of establishment, company size, location of
headquarters, location of bioanalytical facilities, type of offering (in vitro
and in vivo), type of bioassay(s) offered (pre-developed assay and customized
assay), type of bioanalytical services (immunoassay, potency assay, qualitative
PCR, digital droplet PCR, flow cytometry, ELISA, immunochemistry and others)
and application area (cell therapy, gene therapy and others).
§
A detailed
competitiveness analysis of the cell and gene therapy bioassay service
providers based in different geographies, by taking into consideration their
service strength (in terms of bioassay offering(s) and number of bioanalytical
services offered), service applicability (in terms of number of bioassays
offered and application area) and supplier strength (in terms of years of
experience in this field and company size).
§
Tabulated profiles of
key players offering a wide range of cell and gene therapy bioassay services
across North America, Europe and Asia-Pacific. Each profile includes an
overview of the company, financial information (if available), details of its
cell and gene therapy bioassay services portfolio, types of offerings, type of
bioassay(s) offered, types of bioanalytical services offered, application area,
location of bioanalytical facilities, recent developments and an informed
future outlook.
§
An insightful
contemporary market trend analysis, featuring the distribution of cell and gene
therapy service providers by type of bioanalytical services offered and
application area and an analysis of cell and gene therapy service providers,
based on type of bioassay and types of bioanalytical services offered. Further,
the chapter also features a schematic world map representation, highlighting
the location of bioanalytical facilities of cell and gene therapy bioassay
service providers.
§
A detailed analysis
of the global events attended by the service providers, based on year of event,
type of event, type of services involved and application area, and strategic
initiatives taken by various cell and gene therapy bioassay service providers.
§
A case study of the
overall landscape of cell and gene therapy therapeutics market, based on a
number of parameters. The market landscape of cell therapies, features
distribution of cell therapies across phase of development, therapeutic area
and type of developer. Further, the market landscape of cell therapies,
features distribution of gene therapies across phase of development of pipeline
candidates and key therapeutic areas. The chapter also features information on
the developers involved in the domain of cell and gene therapies.
§
An in-depth analysis
of more than 260 cell therapy developers that are anticipated to partner with
cell and gene therapy bioassay service providers and have been shortlisted on
the basis of several relevant parameters, such as developer strength (which
takes into account a company’s size and its experience in this field), pipeline
strength and maturity (based on the number of pipeline drugs and affiliated
stage of development) and availability of other cell therapy capabilities.
§
An in-depth analysis
of nearly 190 gene therapy developers that are anticipated to partner with cell
and gene therapy bioassay service providers and have been shortlisted on the
basis of several relevant parameters, such as developer strength (which takes
into account a company’s size and its experience in this field), pipeline
strength and maturity (based on the number of pipeline drugs and affiliated
stage of development) and availability of other gene therapy capabilities.
The report also features the likely
distribution of the current and forecasted opportunity across important market
segments, mentioned below:
§ Type
of Therapy
§ Cell
Therapy
§ Gene
Therapy
§ Analysis
by Scale of Operation
§ Clinical
Operation
§ Preclinical
Operation
§ Drug
Discovery Operation
§ Analysis
by Therapeutic Area
§
Oncological Disorders
§
Infectious Diseases
§
Autoimmune Disorders
§
Rare / Genetic Disorders
§
Cardiovascular Disorders
§
Metabolic Disorders
§
Blood Disorders
§
Neurological Disorders
§
Ophthalmological Disorders
§
Other Therapeutic Areas
§ Analysis
by Geographical Regions
§ North
America
§ Europe
§ Asia
Pacific
§ Latin
America
§
MENA
To request sample pages, please visit this link
Key Questions Answered
§
Who are the leading services providers offering bioassay
services related to cell and gene therapies?
§ What
is the relative competitiveness of different cell and gene therapy bioassay
service providers?
§ Which
is the commonly offered bioanalytical service (immunoassay, potency assay,
qualitative PCR, digital droplet PCR, flow cytometry, ELISA, immunochemistry
and others) related to cell and gene therapy?
§ What
are the key trends within the cell and gene therapy bioassay service providers
market?
§ What
kind of initiatives are being taken by stakeholders engaged in this domain?
§ Which
players are likely to partner with cell and gene therapy bioassay service
providers?
§ How
is the current and future opportunity likely to be distributed across key
market segments?
§
What are the anticipated future trends related to
teleradiology services market?
You may also be
interested in the following titles:
1. Cell and Gene Therapy
CROs Market: Industry Trends and
Global Forecast (2nd Edition), 2021-2030
2. Biopharmaceutical CROs
Market: Industry Trends and Global Forecast, 2021-2030
3. Pharmaceutical Contract
Research Services Market: Industry Trends and Global Forecast, 2021-2030
4. Biospecimen Contract
Research Services Market by Therapeutic Area: Industry Trends and
Global Forecast, 2021-2030
Contact
Us
Ben Johnson
+1 (415) 800 3415
Comments
Post a Comment